Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal L Mackall

Showing results (101-110 of 232) with videos related to

Pageof 24
Sort By:
Cancer Research Communications|August 12, 2025
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid TumorsKenneth B DeSantes, Kimberly A McDowell, Paul M Sondel, et al.
Journal of Pediatric Hematology/Oncology|September 10, 2002
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levelsPatrick J Mansky, David J Liewehr, Seth M Steinberg, et al.
Oncoimmunology|September 14, 2020
Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma modelSurya Murty, Samuel T Haile, Corinne Beinat, et al.
Cell|February 22, 2024
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cellsVictor Tieu, Elena Sotillo, Jeremy R Bjelajac, et al.
Blood|May 25, 2004
A dose effect of IL-7 on thymocyte developmentNahed El Kassar, Philip J Lucas, David B Klug, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.
The American Journal of Pathology|May 26, 2007
Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivityAndrej Lissat, Thomas Vraetz, Maria Tsokos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasisMartin Guimond, Aharon G Freud, Hsiaoyin C Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2015
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid TumorsMelinda S Merchant, Matthew Wright, Kristin Baird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-PrimingFederico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, et al.
Pageof 24

Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
Cancer Research Communications|August 12, 2025
A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3-Expressing Relapsed or Refractory Solid TumorsKenneth B DeSantes, Kimberly A McDowell, Paul M Sondel, et al.
Journal of Pediatric Hematology/Oncology|September 10, 2002
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levelsPatrick J Mansky, David J Liewehr, Seth M Steinberg, et al.
Oncoimmunology|September 14, 2020
Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma modelSurya Murty, Samuel T Haile, Corinne Beinat, et al.
Cell|February 22, 2024
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cellsVictor Tieu, Elena Sotillo, Jeremy R Bjelajac, et al.
Blood|May 25, 2004
A dose effect of IL-7 on thymocyte developmentNahed El Kassar, Philip J Lucas, David B Klug, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.
The American Journal of Pathology|May 26, 2007
Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivityAndrej Lissat, Thomas Vraetz, Maria Tsokos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2010
In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasisMartin Guimond, Aharon G Freud, Hsiaoyin C Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2015
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid TumorsMelinda S Merchant, Matthew Wright, Kristin Baird, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-PrimingFederico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, et al.
Pageof 24